Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

The overall uptake of RSV vaccine is low during its first season in those aged 60 years or older in the United States. The ...

A study presented at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death within one ...

A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...

A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...

Recommendations supporting respiratory syncytial virus vaccines marketed by Pfizer (NYSE:PFE) and GSK (NYSE:GSK) made last ...

Though they may be fit and healthy, older adults should know the risks of respiratory illness and how to protect themselves.

ACIP is recommending that adults aged 50 to 59 years who are at increased risk for severe RSV disease receive a single dose of an RSV vaccine.

Each year, approximately 177,000 adults aged 65 and older are hospitalized in the United States due to RSV, and an estimated ...

The health and human services secretary, Robert F. Kennedy Jr., is known for his criticism of advisory panels, most recently ...

Adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) have a 2.7-fold increased risk of death within a year compared to the general population.

Clinical and economic burden of respiratory syncytial virus in adults with acute respiratory infections – a Danish nationwide cohort study. Oral presentation. ESCMID Global 2025.